Global vaccine alliance Gavi and UNICEF have announced a significant price reduction for the R21 malaria vaccine, manufactured by the Serum Institute of India. The cost will drop by 25% — from around $4 to $2.99 per dose — within a year, enabling wider access amid declining international aid. The move is expected to bolster […]Continue Reading
